Nicotinamide: potential for the prevention of type 1 diabetes?
Gale
E A
EA
Department of Diabetes and Metabolism, St. Bartholormew's Hospital, London, United Kingdom.
D018849:Controlled Clinical Trials as Topic; D003922:Diabetes Mellitus, Type 1 / Q000378:metabolism* / Q000503:physiopathology / Q000628:therapy; D005060:Europe; D006801:Humans; D007515:Islets of Langerhans / Q000276:immunology; D009536:Niacinamide / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D011236:Prediabetic State / Q000175:diagnosis / Q000628:therapy
D009536:Niacinamide